Suppr超能文献

连续性动静脉血液滤过治疗急性肾衰竭

[Continuous arteriovenous hemofiltration for the treatment of acute kidney failure].

作者信息

Höfliger N, Keusch G, Baumann P C, Geroulanos S, Glinz W, Largiadèr J, Binswanger U

出版信息

Schweiz Med Wochenschr. 1985 Feb 16;115(7):242-7.

PMID:3983593
Abstract

Continuous arterio-venous haemofiltration (CAVH), a simple technique not employing pumps, was used for treatment of acute renal failure in 25 intensive care patients (mean age 52 +/- 16 [SD] years). Acute renal failure was due to trauma in 9 patients, occurred after surgery in 7 patients and was related to septicaemia in 5 patients, peritonitis in 2 patients and pancreatitis in one patient; in one patient acute renal failure developed during pregnancy after preexisting renal disease. Seventeen patients were oliguric and 8 patients were non-oliguric, with a mean daily urine output of 507 +/- 407 ml. At the start of CAVH the serum creatinine level was 511 +/- 198 mumol/l. The duration of treatment with CAVH was 1 to 36 days (average 9.3 days). Access to the circulation was by cannulation of the femoral artery and vein in 23 patients and by Scribner shunt in 2 patients. After an initial systemic dose of 2000 IU heparin, a continuous infusion of 250-1000 IU/hr into the arterial blood line was administered, adjusted to a partial thrombin time of 58 +/- 28 sec. With this heparin regimen a single haemofilter could be used for an average time of 2.6 +/- 1.2 days. The mean spontaneous filtration rate was 6 +/- 2 ml/min, resulting in the following serum levels: creatinine 490 +/- 187 mumol/l; urea 39 +/- 12.5 mmol/l; potassium 4.5 +/- 0.5 mmol/l. Nine catheter-associated complications occurred in 5 patients. The most important aspect of CAVH was its simplicity, optimal control of fluid balance and the possibility of unlimited parenteral nutrition. Uremia was adequately and continuously controlled. Prognosis of ARF was related to the patients' underlying illness.

摘要

连续性动静脉血液滤过(CAVH)是一种不使用泵的简单技术,用于治疗25例重症监护患者(平均年龄52±16[标准差]岁)的急性肾衰竭。9例患者的急性肾衰竭由创伤引起,7例患者在手术后发生,5例患者与败血症有关,2例患者与腹膜炎有关,1例患者与胰腺炎有关;1例患者在原有肾脏疾病的基础上于妊娠期发生急性肾衰竭。17例患者为少尿型,8例患者为非少尿型,平均每日尿量为507±407ml。CAVH开始时血清肌酐水平为511±198μmol/L。CAVH治疗持续时间为1至36天(平均9.3天)。23例患者通过股动脉和静脉插管建立循环通路,2例患者通过Scribner分流管建立循环通路。在初始给予2000IU肝素的全身剂量后,持续向动脉血路输注250 - 1000IU/小时,并根据部分凝血活酶时间调整至58±28秒。采用这种肝素方案,单个血液滤过器平均可使用2.6±1.2天。平均自发滤过率为6±2ml/分钟,由此得出以下血清水平:肌酐490±187μmol/L;尿素39±12.5mmol/L;钾4.5±0.5mmol/L。5例患者发生了9例与导管相关的并发症。CAVH最重要的方面在于其简单性、对液体平衡的最佳控制以及无限期肠外营养的可能性。尿毒症得到了充分且持续的控制。急性肾衰竭的预后与患者的基础疾病有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验